Sign in

    i3 Verticals (IIIV)

    IIIV Q2 2025: Q3 Revenue Guidance Slumps to 48%, Margins in Mid-20s

    Reported on Jun 24, 2025 (After Market Close)
    Pre-Earnings Price$25.66Last close (May 9, 2025)
    Post-Earnings Price$25.66Last close (May 9, 2025)
    Price Change
    $0.00(0.00%)
    • Strong free cash flow conversion: Executives highlighted that the company expects free cash flow conversion to be well above 2/3, driven by the absence of interest expense and additional interest income, indicating efficient operational cash generation despite divestitures and modest capex increases.
    • Focused public sector strategy and margin improvement: The divestiture of the healthcare RCM business has allowed the company to concentrate on public sector operations, which is reflected in consistent margins and organic revenue growth, paving the way for scalable, higher-margin performance in subsequent quarters.
    • Robust M&A pipeline and market expansion: The management emphasized a strong pipeline of regular small tuck-in acquisitions to bolster strategic market presence, particularly in high-margin areas like utility billing, which supports strong ARR growth and enhanced SaaS momentum.
    • Seasonal Revenue and Margin Weakness: Guidance indicates that Q3 revenues will drop to 48% of the remaining annual revenues with margins dipping into the mid-20s%, potentially pressuring overall performance if this weakness persists.
    • Lackluster Payments Revenue Growth: The payments segment grew only 4% year-over-year this quarter, suggesting that this key area may underperform and not offset other headwinds as anticipated.
    • Delayed Key Contract Impact: The removal of approximately $2.5 million from revenue guidance due to delays with the Manitoba contract raises concerns about future revenue certainty and client engagement.
    1. Free Cash Flow
      Q: What FCF conversion is expected?
      A: Management expects free cash flow conversion to be well over 66% given interest income and steady operations.

    2. Quarterly Cadence
      Q: Q3 vs Q4 revenue and margin outlook?
      A: They project Q3 revenues at about 48% with margins in the mid-20s, recovering in Q4 to the high-20s.

    3. Healthcare Divestiture
      Q: Size of the remaining healthcare business?
      A: The remaining healthcare business is roughly $8M annually with a margin profile similar to public sector operations.

    4. ARR Growth
      Q: What is the ARR growth trend?
      A: ARR grew near 9%, slightly down sequentially due to payments revenue, with expectations to rebound later.

    5. Divestiture Cash
      Q: Will extra taxes affect divestiture cash?
      A: The $64M cash mentioned is net of taxes, with no further charges anticipated.

    6. Deal Pipeline
      Q: What is the focus of new deals?
      A: They plan to pursue regular small tuck-in deals with occasional larger ones, maintaining a sharp public sector focus.

    7. Manitoba Revenue
      Q: Why remove $2.5M revenue from guidance?
      A: The reduction is a conservative adjustment due to customer delays and project sequencing issues in Manitoba.

    8. AI Readiness
      Q: How are customers responding to AI?
      A: There is high interest and strong adoption of AI solutions, addressing clear operational pain points.

    Research analysts covering i3 Verticals.